Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with genetically defined diseases.
Stock is 

Stock Chart

Data Provided by Refinitiv. Minimum 15 minutes delayed.